≡ Menu

The sleepy backwater of passive investing has been rudely disturbed by the clanging of alarm bells. The explosive growth in Exchange Traded Funds (ETFs), especially synthetic ETFs, has been spotlighted as a potential threat to the stability of the global financial system in reports by the G20’s Financial Stability Board (FSB), The International Monetary Fund (IMF), and the Bank for International Settlements (BIS).

The reports warn of a daisy-chain of risks embedded in the design and operation of ETFs. They urge investors, regulators and the ETF industry to take heed.

Having read a flurry of disturbing media articles based on the reports, I dived into the original material hoping to discover the threat had been hyped out of all proportion. Unfortunately not. The FSB talk of “disquieting developments” and the BIS paper draws upon the experience of the sub-prime implosion to warn of the dangers of looking the other way.

There’s a lot to take in, so I will concentrate purely on the potential threats posed by synthetic ETFs (also known as swap-based ETFs) in this article, and deal with physical ETFs later.

What happened to simple ETFs?

Emerging synthetic ETF risks

It’s the runaway success of ETFs that requires the risks to be reassessed. The ETF dream is access to a diversified low-cost portfolio using a simple investment vehicle that can be traded like shares. That’s jacked up global ETF assets under management from $410 billion in 2005 to $1,310 billion in 2010, according to the BIS.

But this rapid rise has fostered innovations like synthetic ETFs that could have unforeseen impacts during times of market turmoil. The reports highlight a number of possible dangers that feed into each other, including:

  • Counterparty risk
  • Collateral risk
  • Liquidity risk
  • Conflicts of interest

Counterparty risk

The most famous example of a counterparty default is Lehman Brothers. In the ETF world, counterparties are most commonly used by synthetic ETFs. Unlike physical ETFs, synthetics don’t use their investors cash to buy the physical underlying assets of the index they track. Instead they buy a total return swap from a counterparty (usually an investment bank) that guarantees to pay the ETF provider the return on the index being tracked.

If the counterparty goes bust then there’s nobody to pay the ETF return. That’s unpleasant but supposedly not disastrous because the counterparty hands over collateral to the ETF that’s meant to cover at least 90% of the ETF’s assets. In an emergency, the ETF provider can sell off the collateral to repay investors.

It’s conflict of interest time again

Unfortunately, all three reports identify potential conflicts of interest in the structure of many synthetic ETFs, to the extent that I’m reminded of playing Jenga on a wobbly kitchen table – in Tokyo.

The problem is that ETF providers and counterparties are often different arms of the same institution – especially in Europe. For example, Db x-tracker ETFs are part of Deutsche Bank and Lyxor ETFs are a chip off the French bank, Société Générale.

The suggestion is that investment banks can save costs in other parts of their business by using ETF collateral baskets as a dumping ground for illiquid, hard-to-sell securities that might otherwise be cluttering up their books. For example, your FTSE 100 ETF might actually be backed by unrated corporate bonds or Japanese small caps.

The FSB suggests that lowering the cost of funding may be the reason why investment banks conjured up synthetic ETFs in the first place:

As there is no requirement for the collateral composition to match the assets of the tracked index, the synthetic ETF creation process may be driven by the possibility for the bank to raise funding against an illiquid portfolio that cannot otherwise be financed in the repo market.

And while that may be good for the banks, it’s not so great for investors in the event of a market crisis.

Collateral risk

Though synthetic ETF assets and investor interests are theoretically covered by collateral, all is not rosy:

  • Illiquid collateral is hard to shift. This could damage the liquidity of ETFs that are forced to sell in order to meet redemptions.
  • The collateral may not adequately cover the ETF’s assets, especially in a falling market.
  • The ETF may not be able to sell pledged collateral, if it is frozen by a bankruptcy administrator when a counterparty fails.

ETFs often maintain collateral worth up to 120% of assets, but as the BIS comments:

Overcollateralisation might provide little comfort, as crisis experience has shown that collateral quality tests and collateral coverage tests designed by rating agencies for structured products did not protect senior tranche holders from losses.

If collateral provides cold comfort and seismic market events heighten the possibility of counterparty default then nervous investors could force a run on synthetic ETFs, as outlined by the BIS:

Patterns of withdrawal from money market funds during the crisis show that institutional investors are likely to be the first to run when markets question the solvency of a fund provider, which can then trigger a broader run on the industry.

Liquidity risk

If the ETF provider faces a tidal wave of redemptions requiring cash to be returned to investors, then a mechanism that has previously been a font of cheap funding could become a strain, in the view of the BIS:

Sudden and large investor withdrawals triggered by market events or counterparty risk concerns can also lead to funding liquidity risk. This risk can propagate through the investment banking function, which might take for granted the access to cheap funding through the swap arrangement with the ETF sponsor.

The evaporation of funds, compounded by congealing collateral, could also compromise the ETF provider’s ability to maintain the market liquidity of synthetic ETFs, according to the FSB:

In case of unexpected liquidity demand from ETF investors, the provider might face difficulties liquidating the collateral and may be faced with the difficult choice of either suspending redemptions or maintaining them and facing a liquidity shortfall at the bank level.

Funding stress at the bank – in the teeth of extreme market conditions – would surely heighten fears of counterparty risk. As the FSB puts it:

Since the swap counterparty is typically the bank also acting as ETF provider, investors may be exposed if the bank defaults. Therefore, problems at those banks that are most active in swap-based ETFs may constitute a powerful source of contagion and systemic risk.

Moreover, the other option of suspending redemptions could have knock on effects for the market-makers who match buyers with sellers on the exchange, adding to the turmoil. The BIS paints the picture:

Because ETF redemptions will require cash to be delivered against collateral assets that might be illiquid, market-making activities could be severely hampered, as funding these assets might take priority. The collapse of funding for individual financial intermediaries could then reinforce funding stresses for the financial system as a whole.

Run for the hills?

Added together it’s enough to make my primal-self want to split my money between the mattress and a hole in the ground. However, all three reports are careful to point out that they’re highlighting potential risks, not an imminent doomsday scenario.

The ETF industry is already responding with talk of how robust their operations are and claiming that the theorised collision of calamities is the kind of black swan that won’t fly.

Still, few saw sub-prime coming either and no doubt that’s contributing to greater regulator vigilance this time.

There’s plenty more in the reports if you fancy a bigger dose of the willies. Warnings about the complexity of leveraged and inverse ETFs, the impact of ETFs and ETCs on their underlying markets… and there’s no need to look smug if you only hold physical ETFs. Security lending programmes leave them exposed to collateral and counterparty risk, too.

I’m not advocating consigning synthetic ETFs to a toxic tank that’s already full of endowment mortgages and split zeroes. We need to see how this one plays out.

But rest assured I’ll be keeping an eagle eye on synthetic ETF risks in the future.

Take it steady,

The Accumulator

{ 21 comments }

Weekend reading: The Economist does pensions

Weekend reading

Some great reads from around the Web.

Hello? Hello? It’s hard to be sure anyone is reading out there, given how the first four-day Brucie Bonus bank holiday of the year has coincided with – well – summer.

London has gone all Club Med, and even I feel like some ascetic monk, sat writing this on a Saturday morning while the sun blazes outside.

But YOU have come to Monevator (or opened your email) despite the competing attractions of burnt Tesco Finest sausages, traffic jams, and ogling the opposite sex in the park, for which I thank you.

Then again, maybe you’re reading on Tuesday.

Either way, the slight swizz is that my post of the week is actually from two week’s ago, when a fabulously detailed special report on pensions popped up at The Economist. But I missed it, and you shouldn’t.

This opening fact sets the tone:

When Gertrude Janeway died in 2003, she was still getting a monthly cheque for $70 from the Veterans Administration—for a military pension earned by her late husband, John, on the Union side of the American civil war that ended in 1865.

The pair had married in 1927, when he was 81 and she was 18. The amount may have been modest but the entitlement spanned three centuries, illustrating just how long pension commitments can last.

And so the gravity of the situation pulls us in:

  • We discover that a couple receiving the maximum US social security entitlement would need a $1.2 million fund to buy the equivalent annuity.
  • We learn that the first person to receive such a payment had only contributed $24.75, yet she withdrew nearly $23,000 and lived until 100.
  • We see how UK life expectancy has risen nearly 18 years, but our once-glorious pension system hasn’t kept up (not least thanks to a certain G. Brown’s dividend raid…)

Make sure you follow the links in the sidebar towards the top of The Economist’s introduction to see all the issues this huge report explores.

[continue reading…]

{ 5 comments }

An update on 2007’s high yield portfolio

The ups and downs of the high yield portfolio reviewed

Back in the day, before the credit crunch – before our most precocious readers were even born – I wrote a series of posts on income investing via a high yield portfolio (HYP) of shares.

I think now may be an opportune moment to create a new HYP for dividend income, and I’ll do so in an upcoming post.

But it seems only right that we first go kick the tyres of the original, four years on.

There were several parts to my HYP series:

  • Grow your income with dividends from high yield shares: HYP Part 1
  • Choosing a good high yield share for the long haul: HYP Part 2
  • Diversifying your portfolio: HYP Part 3
  • Selecting shares for your high yield portfolio: HYP Part 4

The article sequence ended with an example high yield share portfolio in Part 4, which was published on September 26th 2007. (Parts 5 and 6 have still not been completed. Blame the distracting financial crisis!)

Unfortunately I’ve discovered that the table of final picks embedded in Part 4 has been corrupted, and no longer displays. But you can still see the constituents of the portfolio in an update from February 2009.

That update, and the one I’m about to conduct today, suffers from the fact that I haven’t considered income, only the capital value of the shares.

You may argue that reviewing an income portfolio without taking into account income is like reporting from Wimbledon after all the players have gone home. I wouldn’t disagree. Income portfolios are constructed primarily for income, not for capital gain. The latter is left to fend for itself, which should hopefully happen with a well-chosen equity income portfolio, as a rising dividend stream will sooner or later mean rising share prices.

The trouble is when I picked my original demo portfolio, I didn’t consider posterity, and so it wasn’t set up for tracking.

Now, I could spend a few hours retrospectively rebuilding the portfolio with 2007 prices, allocate it say £100,000 of pretend money, and then manually calculate the income due in 2008, 2009, 2010 and in the year to come but, well, I’m still single and I’m not getting any younger.

If anyone out there has some spare time and would like to do so and report back in the comments below, I’m sure we’d all be very grateful!

The 2007 HYP and the subsequent bear market

Having explained (though not excused!) the lack of income monitoring with this portfolio, let’s turn to capital.

The idea, rightly or wrongly, was to buy a portfolio of blue chip shares and hold them for the long-term. For the full selection criteria, please see the posts linked to above.

The strategy in short: I selected 20 shares from the upper reaches of the index primarily by yield, looked for diversification between industry sectors, then ditched and replaced companies I didn’t like the look of for some reason (usually debt).

As we all know with hindsight, September 2007 was around the high water mark for the last stock market bull run. A few weeks later the sub-prime doodah hit the fan, making mincemeat of former FTSE darlings, including three constituents of this demo HYP: the bankers at Royal Bank of Scotland, low-end lender Cattles, and housebuilder Taylor Wimpey. Most other shares took a pounding, too.

By the time of my February 2009 update, the demo HYP had fallen in value by 44%. That was worse than the FTSE 100, which had fallen 39% over the same period. (Please read that update for full details).

The 2007 HYP in 2011

So how has the portfolio fared since those dark days of early 2009, which was pretty much the low of the past bear market?

Here’s how things stand as of Friday 15th April’s closing prices:

Company 2007 2011 Change %
A&L (delisted) 733 317 -416 -57%
RBS 517 43 -474 -92%
Tomkins (delisted) 222 325 103 46%
Taylor Wimpey 258 37 -221 -86%
Cattles (delisting) 348 1 -347 -100%
Investec 503 475 -28 -5%
BT Group 305 191 -114 -37%
Hiscox 256 403 147 57%
Royal Sun Alliance 148 133 -15 -10%
Signet Group 1621 2688 1068 66%
Pearson 739 1098 359 49%
National Grid 791 605 -186 -23%
Tate & Lyle 560 607 48 8%
Scottish & Southern Elec. 1510 1318 -192 -13%
InchCape (10:1 share consolidation) 4140 350 -64 -92%
IMI 535 989 454 85%
GlaxoSmithKline 1318 1259 -59 -4%
British American Tobacco 1777 2559 782 44%
BP 567 456 -111 -20%
Unilever 1590 1957 367 23%
Overall
2007 High Yield Portfolio -8%
FTSE 100 6,433 5,996 -7%

Note: All rounded to zero decimal places.

Looking at the portfolio, we see the usual lurches and collapses that happen in any portfolio of individual shares.

Most strikingly, two of the companies are no longer quoted: Alliance and Leicester was acquired by Santander, and Tomkins by a bunch of Canadian pensioners. Furthermore, benighted Cattles is in the process of being taken over, and its suspended listing will soon be wiped away entirely.

Of the remaining shares, the best performer has been IMI, which is 85% higher than in 2007. That’s a huge bounceback from 2009, when it was 48% lower.

InchCape might flatter to deceive if you look at my post from 2007. The share price appears to have advanced handily since then, but in reality the company did a 10-for-one share consolidation in 2010. InchCape almost went bust in 2009, and while management is to be congratulated for avoiding that fate, it’s still smells a bit to hide the body like this.

Overall, we still see the HYP is trailing the market, though only by 1% now as opposed to 5% back in 2009. This may be surprising, given the near blowouts of the likes of Cattles and that our only selection from the booming commodities sector that dominates the FTSE is error prone BP. In my experience it’s not unusual for HYPs, though, probably because the high yield is an indicator of value in some shares, as much as lurking calamity in others. Over time, it evens out.

As for income, the initial yield was almost 4.8% versus less than 3.2% for the FTSE 100, but as warned above I have no numbers on how income has done in practice. The likes of Pearson and Glaxo have kept delivering the dividends, but RBS, BP and Cattles certainly haven’t!

Final thoughts on this portfolio

This is a very rough review. Not only does it ignore income, but I’ve not included other factors such as that you would have reinvested your A&L and Tomkins takeover money back into a rising market.

That might have reduced the performance gap with the FTSE 100 a tad further. In addition, there would have been no charges to pay over the four years of holding the shares, though given the low-cost of the best FTSE 100 index trackers these days, it will have made negligible difference.

More importantly, it’s very possible I’ve missed certain critical facts out from my quick calculations above. I almost missed the InchCape share consolidation, for instance. There could have been others, or on the plus side special dividends.

While you’d have certainly been paying more attention if they were your shares, all this fuss highlights a big advantage of a passive ETF approach to investing. Another alternative is to buy income investment trusts or even white list funds (make sure you go through a discount broker to get initial charges rebated) and to let the managers worry about takeovers and bankruptcies.

But some of us will always actively enjoy owning companies. Also, income trusts are now trading at a premium, which means every £1 you invest buys less than £1 of assets. Not a great deal, considering most are only holding big liquid blue chips.

For that reason and more, I think now might be a good time for share enthusiasts to construct a new high yield portfolio. And I’ll be doing so next week!

As for the 2007 portfolio, this is probably its final public outing. The chances of introducing errors is only going to increase as the years go by, which makes the whole exercise pointless.

If anyone has a favorite online portfolio tool they can recommend for tracking the new HYP over the long-term (one that automatically accumulates dividend income please!) then do let me know below.

{ 18 comments }

Weekend reading: Black Swan blues

Weekend reading

Excellent reading from the Worldy Wise Web.

Once upon a time, Black Swans were rarer than golden geese. But then Nicholas Taleb wrote his bestseller The Black Swan (not to be confused with the pouting Natalie Portman vehicle) and Black Swans have ever since been ruffling feathers everywhere.

I have nothing against Taleb’s dark tome, although I prefer his earlier Fooled by Randomness, which could genuinely change your investing life.

But I do object to the ceaseless reaching for the Black Swan metaphor whenever anything happens that someone doesn’t like the look of.

  • “A nuclear reactor has blown up – it’s a Black Swan event!”
  • “Reckitt Benckiser’s CEO resigns – another Black Swan!”
  • “The market is down today – Black Swan! Black Swan!”
  • “Why knew ISA rates would fall to 3%? Talk about Black Swans.”

No, please don’t talk about Black Swans, not until you can tell one from a duck.

Anyway, The Motley Fool ran such an excellent piece on spotting Black Swans versus red herrings that I’m making it today’s post of the week.

The author, Vincent Scheurer, writes:

The rule that all swans are white was never logically provable. However, the first person to see a real black swan (in 1697) immediately knew that the rule that all swans are white was wrong.

The point about the “Black Swan” in the modern sense of the word — the unexpected event with terrible consequences — is that it cannot be predicted in advance, which means that we as a society must take steps to ensure that its impact is minimised rather than spending all of our resources trying to stop it from happening in the first place.

That, in a nutshell, is why most of the efforts going into financial re-regulation are a waste of time.

[continue reading…]

{ 9 comments }